The GoTaq Probe 1-Step RT-qPCR System is a ready-to-use master mix of optimised components for RT-qPCR using hydrolysis probes. Credit: Promega Corporation.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Centers for Disease Control and Prevention (CDC) has added Promega’s amplification reagent GoTaq Probe 1-Step RT-qPCR System to its coronavirus (Covid-19) diagnostic protocol for emergency use.

Promega’s system is a ready-to-use master mix of optimised components for RT-qPCR using hydrolysis probes.

It is designed for sensitive detection and quantification of a broad range of DNA or RNA targets in the presence of a wide range of PCR inhibitors.

The US Food and Drug Administration (FDA) recently approved an amendment to the CDC’s diagnostic Covid-19 assay that includes an acknowledgement that GoTaq is an approved amplification reagent for laboratories that use the CDC’s assay.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

CDC’s assay protocol is used by several public health labs and clinical testing labs across the US and is referenced by labs globally.

Promega Clinical Diagnostics director Heather Tomlinson said: “Thanks to the CDC acting quickly to make product additions to their protocol, labs now have one more CDC-approved master mix when performing the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel.

“The Promega GoTaq Probe 1-Step RT-qPCR System expands the testing capacity in the US by being another option for labs to use for the amplification process in the CDC’s testing protocol.”

The company supplies automation, sample extraction and diagnostic reagents across the world. Promega accelerated the production in January to address unprecedented demand for Covid-19-related tools.

Currently, Promega reagents are incorporated in 15 Covid-19 diagnostic tests developed by different global diagnostic manufacturers.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact